Graphene oxide-based drug delivery vehicles: functionalization, characterization, and cytotoxicity evaluation
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Sami Makharza | - |
dc.contributor.author | Giuseppe Cirillo | - |
dc.contributor.author | Alicja Bachmatiuk | - |
dc.contributor.author | Imad Ibrahim | - |
dc.contributor.author | Nicholas Ioannides | - |
dc.contributor.author | Barbara Trzebicka | - |
dc.contributor.author | Silke Hampel | - |
dc.contributor.author | Mark H.Rummeli | - |
dc.date.available | 2015-04-20T06:33:54Z | - |
dc.date.created | 2014-09-30 | - |
dc.date.issued | 2013-11 | - |
dc.identifier.issn | 1388-0764 | - |
dc.identifier.uri | https://pr.ibs.re.kr/handle/8788114/1210 | - |
dc.description.abstract | As a consequence of graphene oxides (GOs) high chemical versatility, there is great interest in functionalized as a nanocarrier for in vitro and in vivo drug delivery. Within this review, the structure and properties of GO that allow covalent and noncovalent functionalization are discussed. In short, toxicity investigations show functionalized GO is biocompatible. Various works demonstrate the potential of GO derivatives as exciting nanocarriers for the loading and delivery of therapeutic drugs. | - |
dc.description.uri | 1 | - |
dc.language | 영어 | - |
dc.publisher | SPRINGER | - |
dc.subject | Graphene oxide | - |
dc.subject | Nanocarrier | - |
dc.subject | Drug therapy | - |
dc.subject | Health effects | - |
dc.subject | Nanomedicine | - |
dc.title | Graphene oxide-based drug delivery vehicles: functionalization, characterization, and cytotoxicity evaluation | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.identifier.wosid | 000326810000001 | - |
dc.identifier.scopusid | 2-s2.0-84887035712 | - |
dc.identifier.rimsid | 5824 | ko |
dc.date.tcdate | 2018-10-01 | - |
dc.contributor.affiliatedAuthor | Alicja Bachmatiuk | - |
dc.contributor.affiliatedAuthor | Mark H.Rummeli | - |
dc.identifier.doi | 10.1007/s11051-013-2099-y | - |
dc.identifier.bibliographicCitation | JOURNAL OF NANOPARTICLE RESEARCH, v.15, no.12, pp.1 - 26 | - |
dc.citation.title | JOURNAL OF NANOPARTICLE RESEARCH | - |
dc.citation.volume | 15 | - |
dc.citation.number | 12 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 26 | - |
dc.date.scptcdate | 2018-10-01 | - |
dc.description.wostc | 40 | - |
dc.description.scptc | 38 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.subject.keywordPlus | WALL CARBON NANOTUBES | - |
dc.subject.keywordPlus | CHEMICALLY CONVERTED GRAPHENE | - |
dc.subject.keywordPlus | EXFOLIATED GRAPHITE OXIDE | - |
dc.subject.keywordPlus | WATER-SOLUBLE FULLERENE | - |
dc.subject.keywordPlus | RAMAN-SPECTROSCOPY | - |
dc.subject.keywordPlus | PHOTOTHERMAL THERAPY | - |
dc.subject.keywordPlus | MECHANICAL-PROPERTIES | - |
dc.subject.keywordPlus | PULMONARY TOXICITY | - |
dc.subject.keywordPlus | CONTROLLED-RELEASE | - |
dc.subject.keywordPlus | OXIDATIVE STRESS | - |
dc.subject.keywordAuthor | Graphene oxide | - |
dc.subject.keywordAuthor | Nanocarrier | - |
dc.subject.keywordAuthor | Drug therapy | - |
dc.subject.keywordAuthor | Health effects | - |
dc.subject.keywordAuthor | Nanomedicine | - |